Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

98 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-14

Study Completion Date

2018-04-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tourette syndrome (TS) is characterized by the presence of multiple vocal and motor tics. Behavioral disorders associated with TS are common, particularly impulsivity, anti-sociality and socially inappropriate behavior. Specifically, cognitive impulsivity could be the source of these troubles. Its anatomical substrates is based on connections between frontal and striatal areas.

Initially, a battery of behavioral tests measuring different types of impulsivity (motor, cognitive and decision) will be administered on three groups of subjects: TS: 80 patients (40 patients treated and 40 untreated) and 40 healthy volunteers.

Then, investigators will study the fronto-striatal connections in the TS group of 80 patients (40 patients treated and 40 untreated) compared to 40 healthy volunteers using neuroimaging techniques (3T MRI). The techniques used will be functional connectivity study of "resting state" MRI (RS-fMRI) combined with a reconstruction of white matter fibers by diffusion tensor imaging (DTI). Behavioral performance will be correlated with the correlation imaging data to highlight the functional anatomical substrates of impulsivity in patients with TS.

Finally, investigators will look specifically using functional MRI activation, the anatomical and functional substrates of the three types of impulsivity (motor, cognitive and decision-making).

Through this study, investigators hope to elucidate the anatomical and functional bases of cognitive impulsivity in patients with TS and thus lay the basis for more targeted treatments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability

NCT02914951

Autism Intellectual Disability

ENROLLING_BY_INVITATION NA

Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol

NCT04912089

Anxiety Disorders Depression Posttraumatic Stress Disorder

COMPLETED NA

Effectiveness of Trauma-Focused Cognitive Behavioral Therapy in Treating Children With Post-Traumatic Stress Disorder

NCT00614068

Post-Traumatic Stress Disorder

COMPLETED NA

Effectiveness of Cognitive Behavioral Couples Therapy for Post-traumatic Stress Disorder

NCT00669981

Post-traumatic Stress Disorder

COMPLETED PHASE2/PHASE3

Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses

NCT00494650

Post-Traumatic Stress Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tourette Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TREATED PATIENT WITH TOURETTE SYNDROME

comportemental tasks included impulsivity tests will performed at V1 Resting state IRM will be performed at V2 40 patients

Group Type ACTIVE_COMPARATOR

IRM and comportemental tasks

Intervention Type OTHER

UNTREATED PATIENT WITH TOURETTE SYNDROME

comportemental tasks included impulsivity tests will performed at V1 Resting state IRM will be performed at V2 40 patients

Group Type ACTIVE_COMPARATOR

IRM and comportemental tasks

Intervention Type OTHER

Healthy volunteers

comportemental tasks included impulsivity tests will performed at V1 Resting state IRM will be performed at V2 80 subjects

Group Type PLACEBO_COMPARATOR

IRM and comportemental tasks

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IRM and comportemental tasks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For all subjects:

* ≥ about 18 and 65 years old
* About receiving Social Security or universal health coverage or any equivalent plan
* About who signed the informed consent

For TS patients treated :

* TS principal diagnosis, based on the DSM-5 criteria
* Stable pharmacological treatment at least 4 weeks prior to study entry;
* Possibility of controlling the majority tics of the upper part of the body lying down for at least 10 minutes (frequency tics on YGTSS \<3).

For TS patients untreated:

* TS principal diagnosis, based on the DSM-5 criteria
* No psychotropic treatments (neuroleptics, antidepressants or anxiolytics) mentioned at the time of inclusion.
* Possibility of controlling the majority tics of the upper part of the body lying down for at least 10 minutes (frequency tics on YGTSS \<3).

In healthy volunteers:

* Normal neurological examination (evaluation MINI).
* No regular pharmacological treatment with the exception of birth control pills for women

Exclusion Criteria

For all patients TS:

* Age \<18 years.
* Presence One of the following diagnoses Axis I DSM-5: schizophrenic disorders or current psychotic episode or in the past, bipolar disorder, current major depressive disorder autism spectrum.
* Abus Psychotropic substance dependency or a psychotropic substance, including alcohol (except nicotine).
* Support Regular / chronic drugs and other xenobiotics tropic psychotropic.
* Support Treatment with benzodiazepines in the 4 months prior to study entry. -Patient Subject to a measure of legal protection (guardianship, curatorship or safeguard justice). -No private freedom by administrative decision or justice.
* No Unable to consent and are not subject to a protection measure.
* Participation In other biomedical research or subjected to an exclusion period for another search.
* Problems General understanding.
* Weight Of more than 150 kg.
* Inability To maintain an upper portion of movement of the body lying down for at least 10 minutes (frequency tics on YGTSS\> 3).

In healthy volunteers (HV):

* psychiatric disorders, cognitive impairment assessed by the MINI scale.
* About not being able to understand the tasks
* age \<18 years.
* No Subject to a measure of legal protection (guardianship, curatorship or safeguard justice).
* Participation In other biomedical research or subjected to an exclusion period for another search.
* Not Unable to consent and are not subject to a protection measure.
* Not private freedom by administrative decision or court

For TS patients (treated and untreated) and HV

* relative to MRI 3Tesla : pacemaker, cardiac cell or neural stimulator ferromagnetic surgical clips body intraocular or intracranial metallic foreign cochlear implant artificial heart valve or arterial metal surgical equipment metallic material that could concentrate the radio frequency pulses pregnant women, women in labor or lactating aneurism Standing up the eyelids vascular malformation of the brain
* Topic not wishing to be informed of a clinically significant abnormality discovered during the realization of MRI

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes